Tumors Clinical Trial - A Study of Atezolizumab in Advanced Solid Tumors

Status Completed

Clinical Trial Summary

The primary efficacy objective for this study is to evaluate non-progression rate (NPR) at 18 weeks in participants with advanced solid tumors treated with atezolizumab, defined as the percentage of participants with complete response (CR), partial response (PR), or stable disease (SD) as assessed by the investigator according to Response Evaluation Criteria in Solid Tumors (RECIST) Version (v) 1.1, or according to disease-specific criteria for prostate cancer and malignant pleural mesothelioma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Tumors

Clinical Trial Details

NCT number	NCT02458638
Study type	Interventional
Source	Hoffmann-La Roche
Contact
Status	Completed
Phase	Phase 2
Start date	July 16, 2015
Completion date	July 28, 2020

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT01562626` - Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors	Phase 1/Phase 2
Completed	`NCT00435669` - A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)	Phase 1
Completed	`NCT00400023` - A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors	Phase 1
Completed	`NCT00375245` - Rapamycin With Grapefruit Juice for Advanced Malignancies	Phase 1
Completed	`NCT00410696` - Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy	Phase 2
Completed	`NCT00395434` - Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors	Phase 1
Completed	`NCT00372437` - A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine	Phase 1/Phase 2
Recruiting	`NCT00553033` - Laparoscopic Liver Resection	N/A
Completed	`NCT00248404` - NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)	Phase 1/Phase 2
Completed	`NCT00222443` - Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy	Phase 1
Completed	`NCT00207103` - MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors	Phase 1
Terminated	`NCT03251924` - A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT05103969` - Cohort of Tumors With POLE/D1 Mutation
Completed	`NCT00446446` - PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)	Phase 2
Completed	`NCT02275910` - Phase 1 Study of E7090 in Subjects With Solid Tumor	Phase 1
Terminated	`NCT02271516` - to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage	Phase 1
Completed	`NCT01448759` - Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel	N/A
Terminated	`NCT01081808` - Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors	Phase 1
Completed	`NCT00389480` - Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies	Phase 1
Completed	`NCT00398814` - Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers	Phase 1